| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first telesurgery performed with the Company's SSi Mantra Tele Surgeon Console (the "TSC"). The TSC is a compact self-contained chair-based version of the larger SSi Mantra surgeon command center that enables portability, requires less space, and facilitates the performance of telesurgeries from a wide range of settings including physician offices.
The Company first showcased this disruptive innovation at the Society of Robotic Surgery Meeting held in Orlando in June 2024 and since then has made a number of technological refinements to the TSC. On October 17, 2025, Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, utilized the TSC for the first time to remotely perform a robotic assisted coronary artery bypass procedure from his residence in New Delhi, India on a patient located approximately 185 miles away at Manipal Hospital in Jaipur, India. This milestone demonstrates the benefits of the TSC's compact design, which enables the provision of surgical expertise from the office of any physician without requiring the resources of an entire operating room.
Posted In: SSII